Zachary Starr is a three-time founder with a background in consumer health and finance. After studying at West Chester University, he launched Quix Labs to tackle nicotine addiction through behavioral-first design. He leads the company’s vision, strategy, and execution, driving growth across pharmacy channels in the UK, EU, and U.S. markets.

Anthony Musacchio is a finance leader with a background in private equity and venture investing. He previously advised clients like Goldman Sachs, KKR, and Blackstone while at Deloitte. At Quix Labs, he serves as CFO, overseeing capital strategy, fundraising, and financial operations to support scalable, compliant growth across international nicotine cessation markets.

Ryan Mazur is a chemical engineer and exited founder with deep experience scaling operations in regulated industries. He was a subcontractor to Johnson & Johnson during the COVID-19 pandemic, designing clean rooms for vaccine R&D. At Quix Labs, he leads operations, manufacturing, and supply chain—ensuring the company scales efficiently across the UK, EU, and future U.S. markets.

Dr. Jeff Vaughan, PharmD, led the Department of Defense’s largest smoking cessation clinics during his military service. A former USAF pharmacist and medical science leader at Juul, he brings deep clinical, regulatory, and product experience. At Quix Labs, he ensures safety, compliance, and clinical strategy as the company expands its innovative nicotine reduction solution globally.